换一批Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
第一作者：
Simon E,Richardson
第一单位：
Royal Free Hampstead NHS Trust, London, UK.
作者：
医学主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验(主题)(Clinical Trials as Topic);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);女(雌)性(Female);移植物存活(Graft Survival);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);免疫抑制剂(Immunosuppressive Agents);免疫疗法, 过继(Immunotherapy, Adoptive);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);白细胞分离术(Leukocyte Reduction Procedures);淋巴细胞输注(Lymphocyte Transfusion);男(雄)性(Male);中年人(Middle Aged);多中心研究(主题)(Multicenter Studies as Topic);肿瘤, 残余(Neoplasm, Residual);预后(Prognosis);复发(Recurrence);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);挽救疗法(Salvage Therapy);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome)
DOI
10.1111/bjh.12197
PMID
23293871
发布时间
2017-11-16
- 浏览6
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
